PUBLISHER: Grand View Research | PRODUCT CODE: 1553649
PUBLISHER: Grand View Research | PRODUCT CODE: 1553649
The UK continuous renal replacement therapy market size is anticipated to reach USD 131.7 million by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by numerous factors such as technological advancements such as innovations in design, materials, and manufacturing processes. These advancements have improved the safety, efficiency, and efficacy of CRRT treatments.
One of the most significant advancements in CRRT technology is the development of faster and more efficient filtration systems. New membrane technologies, such as hollow-fiber membranes and nanofiltration, have increased filtration rates and reduced treatment time. This means that patients can receive more effective treatment while minimizing the risk of complications like hemolysis and bleeding. Further, new tubing materials, such as heparin-coated lines, have minimized blood trauma and reduced the risk of complications like hemolysis. This is particularly important in patients with compromised blood vessels or those who are at risk of bleeding.
Moreover, key manufacturers in the industry are prioritizing the development and implementation of digital technologies to enhance knowledge of CRRT among healthcare professionals. For instance, in March 2024 Fresenius Medical Care recently launched an innovative Augmented Reality (AR) application. This cutting-edge technology enables nursing staff to learn Kidney Replacement Therapy in Intensive Care Units more effectively. The AR glasses, paired with digital learning modules, allow nursing staff to gain hands-on experience with acute dialysis machines directly within the intensive care wards. As users interact with the machines, the glasses stream visual and acoustic recordings, providing a comprehensive and immersive learning experience for healthcare professionals.